바이오텐 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 파인밸류자산운용, was filed 19 Nov 2024.
바이오텐: what insiders have been doing
바이오텐 is a Health Care company. Its directors and officers file their transactions with DART (FSS). The past year has been quiet: not a single insider filing for 바이오텐. The previous disclosure was published on 6 November 2025.
Over the whole record (from 2023), the tally stands at 8 purchases and 1 sale.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleFinancial data
· cache
- 138,322 sharesKRXDART:20251106000154
- 2,680 sharesShareKRXDART:20241119000203Canonical exit: 17 Feb 2025 (T+90)
- 2,680 sharesKRXDART:20241119000199Canonical exit: 13 Feb 2025 (T+90)
- ShareKRXDART:20231020000290Canonical exit: 11 Jan 2024 (T+90)
- ShareKRXDART:20231020000310Canonical exit: 11 Jan 2024 (T+90)
- 2,680 sharesKRXDART:20231020000274Canonical exit: 11 Jan 2024 (T+90)
- 2,680 sharesKRXDART:20231019000266Canonical exit: 11 Jan 2024 (T+90)
- ShareKRXDART:20231018000311Canonical exit: 11 Jan 2024 (T+90)
- 2,680 sharesKRXDART:20231018000299Canonical exit: 11 Jan 2024 (T+90)
9 of 9 declarations
About 바이오텐
Bio10 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions in the healthcare sector.
